Stock Analysis of Abeona Therapeutics Inc (ABEO) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code ABEO
Close 4.64
Change -0.0200 / 0.429 %
Volume 408628
Vol Change 260731 / 176.29 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthBearish
Growth Index Very Low Growth Stock
Value Index Poor Value Stock
Profitability Index Poor Profitability Stock
Stability Index Very Low Stability Stock


Fundamental View of Abeona Therapeutics Inc
PE (TTM)

-286.08

Very Poor
Price / Book

1065.66

Very Poor
Price / Sales

4003.15

Very Poor
Piotroski F Score

1.0

Very Poor
Market Cap

114948 K

Enterprise Value

102504 K

ROA (TTM)

-124.59

Very Poor
ROE (TTM)

-372.50

Very Poor
Net Margin (TTM)

-1399.29

Very Poor
Revenue

52.87 %

1414.00 K
Net Profit

48.81 %

-43478.00 K
Debt to Equity

0.066

Excellent
Altman Z Score

-14.65

Very Poor
Quick Ratio

6.78

Excellent
Cash Ratio

6.70

Excellent


Highs/Lows of Abeona Therapeutics Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week4.81 3.53 % 0.425 % 5.1414.3229-Nov-2304-Dec-23
Two Week4.22 9.95 % 0.493 % 5.384.0727-Nov-2324-Nov-23
One Month4.49 3.34 % 4.85 % 5.383.827-Nov-2310-Nov-23
Three Month4.19 10.74 % 1.20 % 5.383.627-Nov-2321-Sep-23
Six Months3.31 40.18 % 6.71 % 5.38962.8522-Jun-2308-Aug-23
One year3.99 16.29 % 12.23 % 5.38962.1922-Jun-2324-Feb-23
Two year14.375 67.72 % 0.691 % 5.38962.1922-Jun-2324-Feb-23
Five year189.75 97.55 % 69.25 % 5.82.1911-Oct-2224-Feb-23
Ten year334.875 98.61 % 154.89 % 750.02.1924-Mar-1424-Feb-23


Technical View of Abeona Therapeutics Inc
RSI

37.83

Neutral
MACD

-0.0377

Bullish
ADX

18.19

Neutral
Super Trend

3.58

Mild Bullish
Williams %R

-98.62

Mild Bullish
CCI

-213.75

Mild Bullish


EMA 5

3.87

Mild Bearish
EMA 15

4.03

Strong Bearish
EMA 50

3.99

Strong Bearish
EMA 100

3.85

Strong Bearish
SMA 100

3.98

Strong Bearish
SMA 200

3.39

Mild Bullish
SMA 5 / 20

3.88 / 4.13

Bearish
SMA 15 / 50

4.11 / 4.05

Bullish
SMA 50 / 200

4.05 / 3.39

Mild Bullish




Charts of Abeona Therapeutics Inc


Returns of Abeona Therapeutics Inc with Peers
Period / StockABEOBLRXSYANIX
1 Week-3.53%10.27%0%19.03%
1 Mth3.34%-1.23%25.51%14.60%
3 Mth10.74%-20.30%-18.06%1.37%
6mth40.18%-3.01%-46.36%10.81%
1 Year16.29%123.61%41.15%-24.54%
2 Year-67.72%-27.48%-67.40%19.42%
5 Years-97.55%-83.76%-7.29%


Compare Fundamentals of Abeona Therapeutics Inc with Peers
Ratio / StockABEOBLRXSYANIX
PE-286.08-23.263.19-11.23
P/B1065.6632.230.04474.16
ROA-124.59-73.551.13-34.80
ROE-372.50-138.571.46-35.93
Debt To Equity0.0660.2080.02010.0016
Revenue1414.00 K
52.87 % 		0
% 		1257.87 M
25.68 % 		2469.00 M
481656 %
Net Income-43478.00 K
48.81 % 		-18872.00 K
30.24 % 		-66107.00 K
75.65 % 		-13595.00 K
4.95 %


Technicals of Abeona Therapeutics Inc with Peers
Technical / StockABEOBLRXSYANIX
ADX29.5514.8022.5019.93
CMF-0.0650.0740.086-0.086
MFI60.0847.1274.1685.22
RSI57.5954.6358.7569.69
MACD Abv SignalTrueTrueFalseTrue
Price Above 50 MATrueTrueTrueTrue
Price Above 200 MATrueTrueFalseTrue


About : Abeona Therapeutics Inc

Address : 1330 Avenue of the Americas, New York, NY, United States, 10019
Tel : 646 813 4701
URL : https://www.abeonatherapeutics.com
Code : ABEO, ISIN : US00289Y1073, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 19_Sep_1980
Employee Count : 57

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is EB-101, an autologous, engineered cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 for the treatment of X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 for the treatment of autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. is headquartered in New York, New York.


Note : All Data Generated at the End of Trading Hours (EOD Data)